Cargando…
STING palmitoylation as a therapeutic target
Gain-of-function mutations in the STING-encoding gene TMEM173 are central to the pathology of the autoinflammatory disorder STING-associated vasculopathy with onset in infancy (SAVI). Furthermore, excessive activity of the STING signaling pathway is associated with autoinflammatory diseases, includi...
Autores principales: | Hansen, Anne Louise, Mukai, Kojiro, Schopfer, Francisco J., Taguchi, Tomohiko, Holm, Christian K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460494/ https://www.ncbi.nlm.nih.gov/pubmed/30796349 http://dx.doi.org/10.1038/s41423-019-0205-5 |
Ejemplares similares
-
Activation of STING requires palmitoylation at the Golgi
por: Mukai, Kojiro, et al.
Publicado: (2016) -
Nitro-fatty acids are formed in response to virus infection and are potent inhibitors of STING palmitoylation and signaling
por: Hansen, Anne Louise, et al.
Publicado: (2018) -
The activity of disease-causative STING variants can be suppressed by wild-type STING through heterocomplex formation
por: Shindo, Ruri, et al.
Publicado: (2022) -
STING Operation at the ER/Golgi Interface
por: Taguchi, Tomohiko, et al.
Publicado: (2021) -
Marine diterpenoid targets STING palmitoylation in mammalian cells
por: Hsiao, Wan-Chi, et al.
Publicado: (2023)